TABLE 3.
Compound | [Compound] μ M | Markers Induced >2 Fold (p ≤ 0.05) | Fold Induction | % Max | p |
---|---|---|---|---|---|
Control Compounds | |||||
3-Methyl Cholanthrene | 20 | GST Ya (8 hr) | 2.7 | 20 | 0.007 |
20 | GST Ya (24 hr) | 5.0 | 100 | 0.004 | |
7 | HIF1RE | 3.7 | 100 | 0.006 | |
20 | XRE | 5.5 | 48 | 0.001 | |
Calcium ionophore (A23187) | 2 | HSP70 | 3.3 | 8 | 0.020 |
20 | NF-AT | 11.4 | 100 | 0.001 | |
Methane methyl sulfonate (MMS) | 1000 | CJUN | 10.1 | 100 | 0.000 |
1000 | GADD153 | 15.2 | 58 | 0.000 | |
333 | GST Ya (8 hr) | 4.7 | 40 | 0.012 | |
333 | HSP70 | 5.9 | 24 | 0.036 | |
333 | XRE | 2.1 | 12 | 0.004 | |
12-phorbol 13-myristate (PMA) | 0.7 | CJUN | 8.1 | 78 | 0.000 |
0.2 | GADD153 | 25.5 | 100 | 0.001 | |
0.7 | GST Ya (8 hr) | 10.2 | 100 | 0.001 | |
0.2 | HMO | 19.8 | 100 | 0.001 | |
0.2 | HSP70 | 21.7 | 100 | 0.004 | |
0.7 | NF-κ BRE | 1030.0 | 100 | 0.004 | |
2 | NF-AT | 8.6 | 60 | 0.029 | |
0.7 | XRE | 10.2 | 98 | 0.019 | |
Test Compounds | |||||
OSI-97345 | 17 | GST Ya (8 hr) | 2.5 | 16 | 0.005 |
17 | GST Ya (24 hr) | 2.8 | 38 | 0.010 | |
6 | HSP70 | 2.4 | 7 | 0.028 | |
17 | XRE | 5.0 | 44 | 0.000 | |
OSI-102695 | 4.2 | GST Ya (24 hr) | 2.0 | 18 | 0.043 |
1.4 | HSP70 | 2.1 | 4 | 0.043 | |
13 | XRE | 2.5 | 16 | 0.003 | |
OSI-101820 | 14 | XRE | 2.9 | 20 | 0.001 |
OSI-168992 | 1.9 | HIF1RE | 2.2 | 48 | 0.000 |
0.6 | XRE | 2.8 | 20 | 0.003 | |
OSI-168961 | 8 | HIF1RE | 2.4 | 79 | 0.035 |
3 | XRE | 2.3 | 15 | 0.006 | |
OSI-169050 | 14 | GADD153 | 2.3 | 6 | 0.004 |
42 | GST Ya (8 hr) | 2.3 | 13 | 0.009 | |
125 | GST Ya (24 hr) | 2.5 | 27 | 0.003 | |
42 | HIF1RE | 3.3 | 95 | 0.000 | |
42 | XRE | 3.9 | 32 | 0.002 | |
OSI-169170 | 42 | GADD153 | 2.1 | 5 | 0.001 |
14 | GST Ya (8 hr) | 2.1 | 12 | 0.019 | |
OSI-2040 | 10 | CJUN | 2.0 | 11 | 0.006 |
10 | GADD153 | 2.1 | 4 | 0.000 | |
0.4 | HSP70 | 6.8 | 28 | 0.022 | |
10 | NF-κ BRE | 4.1 | 0 | 0.022 | |
0.1 | XRE | 4.2 | 34 | 0.006 | |
Proprionohydroxamic acid (PHA) | < 50 | None | - | - | - |